Morbidity and mortality results from a prospective randomized trial comparing mesorectal excision with or without lateral lymph node dissection for clinical stage II and III lower rectal cancer: Japan Clinical Oncology Group study JCOG0212.S. Fujita, Yoshihisa Saida, Tomoaki Aoki et al.|Journal of Clinical Oncology|2011Cited by 2